Capital Press Capital Press Capital Press
  • Twitter
  • Faceboook
  • Youtube
  • Email
  • Google Plus
Click for Full Story Diverging diagnoses

The deaths of two more patients taking part in a study of Juno Therapeutics' experimental leukemia drug last month was a fresh setback to the highly anticipated new way to treat the cancer.

  1 of 5 
Read Story Dec. 9, 2016
Click for Full Story Trump’s tech boon Dec. 7, 2016
Click for Full Story Consumers feeling bullish Dec. 6, 2016
Click for Full Story Electric car threat? Dec. 3, 2016
Click for Full Story DirecTV: cable killer? Dec. 2, 2016
Market Summary
NYSE COMP 10 Year T Bond 30 Year T Bond AMEX COMP NYMEX Gold Dollar vs. Euro Dollar vs. Yen Crude Oil